FDA Specifies DUNS for Drug Facility Registration
FDA releases guidance specifying its preferred unique facility identifier system.
FDA Specifies DUNS for Drug Facility Registration
FDA has released guidance specifying the unique facility identifier (UFI) system for the registration of domestic and foreign drug establishments. The guidance addresses sections 701 and 702 of the Food and Drug Administration Safety and Innovation Act (FDASIA) that direct FDA to specify the UFI system for registration of domestic and foreign drug establishments.
In the document, FDA states that it is specifying the Data Universal Numbering System (DUNS) number, assigned and managed by Dun and Bradstreet, which FDA has been using since the implementation of electronic drug registration and listing. The DUNS number is available free of charge to all drug establishments, and further information is available on FDA’s website.
Source: FDA
Telix Enters Agreement with ImaginAb to Purchase Next-Gen Therapeutic Candidates
Published: January 13th 2025 | Updated: January 13th 2025The transaction adds a pipeline of early-stage drug candidates against high-value targets to Telix’s portfolio, along with other novel targets currently in the discovery stage.
